Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

Cancer drug prices are soaring, but they don't reflect improvements in patient survival. Instead, prices are often based on market size, not therapeutic value. The cost of cancer drugs paid by ...

Trump's action halted research and implementation of a program meant to lower the cost of prescription drugs for Medicare beneficiaries; it did not, however, affect prescription drug costs for ...

When big pharmaceutical companies merge, the perception is that drug prices rise, but a University of Iowa study finds that’s not always the case. Study co-author Amrita Nain, a professor of ...

An executive order signed by former President Joe Biden aimed at lowering prescription drug prices was among those voided by President Donald Trump's flurry of executive orders this week.

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...

President Donald Trump’s executive order on Day One of his administration to “deliver emergency price relief” doesn’t include prescription drug prices and, for some people, health ...

Aetna alleges generic drugmakers colluded to inflate prices of essential medications, with increases reaching as high as 2,762%. The lawsuit claims a "fair share" market allocation system and ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

SPRINGFIELD, Ill. (WAND) — State lawmakers and advocates are renewing their push to create a prescription drug affordability board in hopes of lowering drug prices. Advocates argue President ...